Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

about

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

Item

http://www.wikidata.org/entity/Q49868941

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

@en

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

@nl

type

Item

label

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

@en

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

@nl

prefLabel

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

@en

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

@nl

P1476

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.

@en

P2093

Deepthika Abeysiriwardhana

http://www.w3.org/2001/XMLSchema#string

Harshini Peiris

http://www.w3.org/2001/XMLSchema#string

Lakmini Mudduwa

http://www.w3.org/2001/XMLSchema#string

Shania Gunasekara

http://www.w3.org/2001/XMLSchema#string

Thusharie Liyanage

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular portraits of human breast tumours

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

Claudin 1 expression in basal-like breast cancer is related to patient age

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Molecular characterization and targeted therapeutic approaches in breast cancer

Best Practice No 176: Updated recommendations for HER2 testing in the UK

P304

1178223417745858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1178223417745858

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29434471

http://www.w3.org/2001/XMLSchema#string

P932

5802694

http://www.w3.org/2001/XMLSchema#string